CVS Health Corporation $CVS Shares Sold by Banque Cantonale Vaudoise

Banque Cantonale Vaudoise reduced its stake in shares of CVS Health Corporation (NYSE:CVS) by 52.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,874 shares of the pharmacy operator’s stock after selling 30,947 shares during the period. Banque Cantonale Vaudoise’s holdings in CVS Health were worth $2,211,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. National Pension Service raised its holdings in shares of CVS Health by 3.1% during the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock worth $301,532,000 after purchasing an additional 119,189 shares during the last quarter. Kingsview Wealth Management LLC raised its holdings in shares of CVS Health by 316.2% during the third quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator’s stock worth $7,873,000 after purchasing an additional 79,340 shares during the last quarter. AE Wealth Management LLC raised its holdings in shares of CVS Health by 6.2% during the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock worth $19,391,000 after purchasing an additional 14,983 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in CVS Health by 11.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock valued at $16,971,000 after buying an additional 22,653 shares in the last quarter. Finally, Assetmark Inc. increased its holdings in CVS Health by 12.5% in the third quarter. Assetmark Inc. now owns 678,558 shares of the pharmacy operator’s stock valued at $51,156,000 after buying an additional 75,603 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Up 0.1%

Shares of NYSE CVS opened at $93.35 on Friday. The company’s 50-day simple moving average is $80.03 and its 200-day simple moving average is $78.98. CVS Health Corporation has a 52-week low of $58.50 and a 52-week high of $98.43. The firm has a market cap of $119.11 billion, a price-to-earnings ratio of 41.12, a price-to-earnings-growth ratio of 0.91 and a beta of 0.60. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The business had revenue of $100.43 billion for the quarter, compared to analyst estimates of $94.99 billion. During the same quarter last year, the business earned $2.25 earnings per share. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Equities analysts predict that CVS Health Corporation will post 7.44 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s payout ratio is presently 117.18%.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of recent analyst reports. TD Cowen lifted their price objective on shares of CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a report on Monday, May 11th. Wall Street Zen raised shares of CVS Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. JPMorgan Chase & Co. lifted their price objective on shares of CVS Health from $101.00 to $111.00 and gave the company an “overweight” rating in a report on Tuesday, May 12th. Mizuho lifted their price objective on shares of CVS Health from $102.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday. Finally, Truist Financial lifted their price objective on shares of CVS Health from $98.00 to $102.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Twenty-two analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $98.68.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Glenview Capital said CVS shares have delivered strong long-term returns and pointed to continued progress in the company’s cultural and operational turnaround, a supportive signal from a notable shareholder. Glenview Capital Issues Statement on CVS Health
• Positive Sentiment: CVS also highlighted new community and public-health initiatives, including senior affordable housing, military support, and maternal mental-health outreach, which reinforce its healthcare platform and brand strength. CVS Health, Diocese of Camden, and The Walters Group Unite to Bring Senior Affordable Housing to Williamstown, New Jersey
• Neutral Sentiment: CVS published several corporate responsibility updates, including support for the military community and women’s health, which are positive for reputation but likely have limited immediate impact on earnings. CVS Health Reinforces Longstanding Support for the Military Community
• Negative Sentiment: Three major hospital systems accused CVS of diverting hundreds of millions of dollars in savings from the federal 340B Drug Pricing Program, increasing legal and reputational risk for the company. Three major hospital systems accuse CVS of secretly siphoning hundreds of millions in drug savings
• Negative Sentiment: Director Larry Robbins disclosed multiple large stock sales over May 19-21, trimming his position by a sizable amount; insider selling can weigh on sentiment even if it does not change the business fundamentals. SEC Form 4 filing

Insider Transactions at CVS Health

In related news, Director Larry Robbins sold 1,983,538 shares of the business’s stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $94.45, for a total transaction of $187,345,164.10. Following the transaction, the director directly owned 6,213,261 shares in the company, valued at approximately $586,842,501.45. The trade was a 24.20% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the transaction, the executive vice president owned 10,133 shares in the company, valued at $907,714.14. The trade was a 87.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 3,441,551 shares of company stock worth $323,703,977 over the last 90 days. 0.85% of the stock is currently owned by company insiders.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.